Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients
Sponsor: Intermountain Health Care, Inc.
Summary
This study evaluates whether achieving 25-hydroxyvitamin D (25\[OH\] Vit D) levels (\>40 ng/mL) among myocardial infarction patients will result in a reduction of cardiovascular-related adverse events. Half of the patients will be randomized to receive standard of care and half will receive clinical management of 25\[OH\] Vit D levels.
Official title: A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients (The TARGET-D Study)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
634
Start Date
2017-04-03
Completion Date
2025-09-04
Last Updated
2026-11-05
Healthy Volunteers
No
Interventions
Vitamin D3
Vitamin D3 (cholecalciferol) will be provided to participants of the study.
Locations (1)
Intermountain Medical Center
Murray, Utah, United States